Articles tagged with Heart Failure
A study published in Circulation found that moderate or vigorous physical activity can lower the risk of developing heart failure. The research, which analyzed data from over 94,000 adults, suggests that increasing physical activity duration and intensity may provide greater protection against heart failure.
The study found that the probability of surviving cardiac arrest outside hospital has more than doubled in 30 years, from approximately 5% to 11%. The improvement is attributed to increased CPR training and better healthcare resources. However, ambulance delays and an increase in difficult-to-treat cases are hindering further progress.
The TCT MedTech Innovation Forum is an intensive summit bringing together clinicians, entrepreneurs, investors, and regulators to identify clinical challenges and drive innovation in medtech. The agenda features interdisciplinary perspectives on unmet clinical needs, financing, regulatory policy, and evolving healthcare delivery models.
Researchers at Temple University hospital found that maternal-fetal mortality can be reduced to zero through patient-tailored management of right heart function prior to delivery. Women with pulmonary hypertension who received specialized care had excellent outcomes, with 100% survival for mothers and infants.
Symptoms of cardiovascular diseases, including heart attack and heart failure, can profoundly affect quality of life. The American Heart Association scientific statement highlights the importance of tracking symptoms to detect changes and progression.
A new study provides critical insights into the pGC-A membrane receptor, a vital component of cardiovascular regulation. The research offers a clearer understanding of this complex receptor and its signaling mechanisms, paving the way for new anti-hypertensive drugs.
Researchers mapped specific gene variants to their effects on cardiac cells, revealing unique responses to different mutations. This study provides insights into the development of precision-targeted interventions for dilated cardiomyopathy and other genetic heart diseases.
Researchers discovered distinct genetic mutations in heart failure patients, identifying potential targets for personalized treatment and improving patient care. The study's findings hold enormous potential for rethinking how to treat heart failure by understanding its root causes and the mutations that lead to changes in heart function.
A study of over 1.4 million women found that premature menopause is associated with a higher risk of heart failure and atrial fibrillation. Women who experienced premature menopause had a 33% higher risk of heart failure and a 9% higher risk of atrial fibrillation compared to those without a history of premature menopause.
A new study reveals racial and gender disparities in access to life-saving heart-assisting implants, with Black patients and women facing lower rates of surgery. Despite similar survival rates, the findings suggest that unconscious bias may be influencing healthcare provider decisions.
A team of researchers, backed by a £30m grant from the British Heart Foundation, aims to develop the first cures for inherited heart muscle diseases using ultra-precise gene therapy technologies. They plan to deploy CRISPR technology to correct or silence faulty genes, potentially delivering an injectable cure within years.
A study of 12,000 Medicare beneficiaries with heart failure at risk for requiring a left ventricular assist device (LVAD) found racial and sex disparities in LVAD access. Adjusting for individual poverty and community-level social determinants of health did not alter the inequity in one-year survival among groups.
Researchers at RCSI University have created a new lab-based model to test devices for heart failure with preserved ejection fraction. The model enables testing of the left atrium and ventricle, two independently controlled chambers that simulate blood flow during the resting phase.
A Spanish study combines genetic and imaging data to predict patient prognosis, identifying those at risk of malignant arrhythmias or severe complications. The findings open the way for personalized medicine in treating dilated cardiomyopathy.
A pooled data analysis of 11 international studies found that NAFLD is associated with a 50% heightened risk of developing heart failure. The severity of NAFLD also increases the risk, especially with extensive liver fibrosis.
Researchers found that high blood pressure doubles the risk of severe COVID-19 hospitalization even after full vaccination and booster doses. The study analyzed adults hospitalized with Omicron-variant COVID-19 in Los Angeles between December 2021 and April 2022.
A recent study by NHCS researchers found that myocardial fibrosis is associated with worse cardiovascular outcomes in patients with hypertension. The study, which used cardiac magnetic resonance imaging (CMR), detected heart muscle scarring and quantified fibrosis in over 800 patients with hypertension.
Research suggests that overly restrictive salt intake may worsen outcomes for people with a common form of heart failure, particularly in younger individuals and those of black and other ethnicities. The study found that participants who consumed more salt had a lower risk of hospital admission for heart failure.
Research finds that losing the Y chromosome increases mortality from cardiovascular disease by up to 1.76 times, with a significant link between Y-chromosome loss and fibrosis promoting heart failure. The study also shows that cardiac macrophages without the Y chromosome produce substances that activate fibroblasts, leading to fibrosis.
Researchers found that men who lose their Y chromosome as they age are more likely to experience deadly heart scarring and earlier death. The study suggests an existing drug may help counteract the effects of this loss, potentially leading to longer, healthier lives for affected men.
A long-term study of 3,926 adults with CKD found that higher levels of physical activity reduced the risk of atherosclerotic events, new-onset heart failure, and death. The association was strongest for incident peripheral arterial disease and reinforces current guideline recommendations.
Grieving a close family member can significantly increase stress levels, contributing to poor prognosis in heart failure patients. The study found that bereavement was associated with increased mortality risk, particularly after death of a child or spouse/partner.
Researchers identified key predictors of cardiac sarcoidosis outcomes, including tachycardia, BNP levels, LVEF, and RFCA use. The study found a high risk of fatal ventricular arrhythmia events and heart failure hospitalizations, emphasizing the need for early diagnosis and treatment strategies.
A new study by University of Missouri found that Black nursing home residents and those under 65 are significantly more likely to experience repeat hospital transfers. This phenomenon can be attributed to various factors including 'full-code' status regarding end-of-life care, comorbidities, and inadequate staffing. The study suggests ...
The Brigham and Women's Hospital will implement and evaluate an integrated service delivery model (PEN-Plus) for severe chronic noncommunicable diseases, such as type 1 diabetes and rheumatic heart disease, in eight low- and lower-middle-income countries. The initiative aims to enable one million of the world's poorest children and you...
A new study found that post-operative atrial fibrillation (POAF) is associated with a higher risk of hospitalization for heart failure among patients undergoing cardiac and non-cardiac surgery. POAF may be an early marker for heart failure, and its presence could contribute to the development of the condition.
A study of over three million patients found that post-operative atrial fibrillation increases the risk of hospitalization for heart failure. The risk is present regardless of whether surgery was performed for a heart condition, and can be as high as doubling in non-heart-related conditions.
A large study found that adult cancer survivors have a 42% greater risk of cardiovascular disease than those without cancer. The highest risks were seen in breast, lung, colorectal, and hematological/lymphatic cancers, while prostate cancer did not significantly increase the risk.
A recent study published in Open Heart found that heart failure is discussed less frequently in public discourse than conditions like cancer and dementia, with 'heart failure' mentioned just 0.28 times per million words in UK parliamentary debates between 1945 and early 2021.
A multi-institutional study found that a virtual approach can be more efficient than traditional trials, with enrollment being about five times faster. The study showed improved symptoms and health status in patients taking a sodium-glucose co-transporter 2 inhibitor (SGLT2i) drug.
Research found significant disparities in cardiac rehabilitation participation by race/ethnicity regardless of income. Cardiac rehabilitation programs combine physical activity with counseling to improve recovery after a major cardiovascular event.
Researchers at the University of Maryland School of Medicine conducted a groundbreaking xenotransplant surgery, implanting a genetically modified pig heart into a 57-year-old patient with terminal heart disease. The patient survived for two months with a strong functioning heart showing no obvious signs of rejection.
A systematic review found that reduced gut microbiome diversity and elevated trimethylamine-N-oxide (TMAO) metabolite levels are associated with increased risk of death and hospital visits in heart failure patients. Further research on the impact of diet and potential interventions is underway.
New technology measures peak velocity of blood flow in the heart accurately, helping doctors diagnose and monitor patients with heart failure. The 4D heart MRI scan provides precise imaging of the heart valves and flow inside the heart, enabling better treatment planning.
A study published in Alzheimer's & Dementia found that individuals with at least two cardiometabolic diseases, such as type 2 diabetes and heart disease, double their risk of developing dementia. The study suggests that prevention of these diseases could be a strategy for reducing dementia risk.
A study found that US adults receiving hemodialysis with high air pollution exposure have more heart attacks and strokes compared to those with low exposure. The strongest associations were noted among patients who were Asian, older, or had chronic lung disease at dialysis initiation.
Researchers discovered that uncontrolled diabetes increases heart failure risk by 1.5 to 1.8 times in preclinical stages A and B. Early diabetes control can prevent progression to overt heart failure, suggesting a potential lifesaving strategy.
A new PET imaging agent, <sup>68</sup> Ga-FAPI-46, has been shown to predict the severity of cardiac remodeling after a heart attack by identifying active fibrosis. This biomarker has potential to aid in diagnosis and treatment selection for patients with heart failure.
Scientists have identified a key mechanism causing the heart's muscle to thicken, leading to irregular rhythms and heart failure. A new peptide treatment could prevent or stop further thickening, offering hope for patients with cardiac hypertrophy.
A new study from Mount Sinai Heart found that heart failure patients unvaccinated against COVID-19 are three times more likely to die from it than those who are fully vaccinated and boosted. The research also shows that these unvaccinated patients face higher risks of hospitalization and ICU admission if infected with the virus.
A long-term study found that cigarette smoking significantly increases the risk of developing both reduced ejection fraction and preserved ejection fraction heart failure. Former smokers retained a higher risk of heart failure for decades after quitting, with the risk decreasing only after 30 years without smoking.
A new study found that sodium-glucose co-transporter 2 inhibitors (SGLT-2i) decreased the risk of hospitalization for heart failure in adults with type 2 diabetes. SGLT-2i showed similar cardiovascular outcomes to metformin but a lower risk of heart failure hospitalization.
A major study found COVID-19's toll on global cardiac services, revealing a 'substantial global decline' in hospital admissions of cardiovascular patients. The pandemic led to increased delays in treatment, resulting in more deaths and complications, with low-income countries facing the worst impact.
A major international study reveals the significant impact of COVID-19 on cardiovascular services worldwide, with a substantial decline in hospital admissions and increased mortality rates. The study warns that problems with heart health will continue to accrue unless mitigation strategies are implemented quickly.
A review of 38 randomized controlled trials found that counseling patients about contraceptive use and providing contraceptives increases use without increasing STI risk or reducing condom use. The interventions also decrease unintended pregnancy in trials designed to evaluate this outcome.
A multi-center study evaluates the Alleviant System, a transcatheter technology that reduces pressure in the left atrium without implantation. The device demonstrates procedural safety and feasibility, with promising efficacy signals through six months.
A study found that colchicine significantly improved survival rates for patients hospitalized with worsening heart failure. Colchicine may also reduce the risk of heart attack and stroke in patients with a buildup of cholesterol in their arteries.
A recent cohort study found that previous cardiovascular conditions, including heart surgery and heart failure, were associated with increased COVID-19 severity in US pediatric patients. The study highlights the importance of pre-existing medical conditions in determining COVID-19 outcomes in children.
The TVT 2022 program features cutting-edge research on transcatheter aortic valve replacement (TAVR) and other structural heart therapies. The meeting will focus on patient evaluation, imaging modalities, and therapeutic options.
A new study published in the European Heart Journal shows that MRI is superior to echocardiography for diagnosing heart failure and predicting patient outcomes. The research found that MRI can accurately measure left ventricular filling pressure, leading to improved diagnosis and reduced need for invasive assessments.
A new study validates the Canadian Syncope Risk Score as a reliable tool to identify patients at low risk for serious outcomes after 30 days, potentially reducing hospitalization rates. The score showed better performance than another validated score, but its clinical utility remains uncertain and warrants further research.
A new study from Massachusetts General Hospital reveals a strong association between infertility and an increased risk of heart failure, particularly in women. Infertility was associated with a 16% increased risk of overall heart failure and a 27% increased risk of HFpEF.
A new study published in the Journal of the American Heart Association found that late menopause, occurring at age 55 or older, significantly increases heart failure risk among obese women. Obesity was a major contributing factor, with the risk being greatest among women who experienced late menopause.
A systematic review and meta-analysis found that SGLT2 inhibitors reduce hospitalizations and cardiovascular deaths in heart failure patients, regardless of diabetes status. The analysis also warned of increased genital infections associated with treatment.
Researchers discovered that Viagra and a common over-the-counter drug TUDCA restored mitochondrial processes, which drive heart failure in HLHS patients. This could lead to new therapies for treating heart failure without relying on heart transplants.
A recent study published in Molecular Therapy Nucleic Acids found that the molecule urocortin-2 may regulate recovery processes after a heart attack by modulating miR-29a. Treatment with urocortin-2 could favor patient recovery by regulating apoptosis and fibrosis.
The study found significant improvements in blood flow through the heart and quality of life at one year, with all 36 patients achieving a reduction in tricuspid regurgitation severity. Longer follow-up is needed to determine how well the device continues to perform.
The study found that patiromer significantly lowers blood potassium levels in patients taking RAASi medications for heart failure. The results suggest that patiromer can be used to control excess potassium buildup in the blood, which is a common side effect of RAASi therapy.
A new study found that customized digital alerts via an electronic health record system significantly increased the number of guideline-directed medications prescribed for heart failure patients. The alerts improved medication use by over a quarter of patients, translating to one medication addition per every 14 alerts received.
A global trial found that people with heart failure who received an annual flu shot had lower rates of pneumonia and hospitalization on a year-round basis. The study also revealed significant reductions in major cardiovascular events during peak flu season.